-
Innovation Ranking
NewInnovation Ranking – ICON Plc
ICON Plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides specialized services that span the entire lifecycle of product development. The company’s service portfolio includes adaptive trials, biosimilars, clinical research services, commercialization and outcomes, consulting, provision of functional services, medical imaging, resourcing solutions, laboratory services and strategic support and tactical solutions for traditional, in vitro diagnostic and software devices. The company offers research services in...
-
Product Insights
Iconic Dev – Iconic Marjorie Hotel – Penang
The Iconic Dev – Iconic Marjorie Hotel – Penang project involves the construction of a hotel with 298 rooms in Bayan Lepas, Penang, Malaysia. Equip yourself with the essential tools needed to make informed and profitable decisions with our Iconic Dev – Iconic Marjorie Hotel – Penang report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ICON-1 in Choroidal Neovascularization
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ICON-1 in Choroidal Neovascularization report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary...
-
Thematic Analysis
Medical Devices M&A Deals 2023 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Medical Devices Sector
-
Product Insights
Idiopathic Pulmonary Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Idiopathic Pulmonary Fibrosis Clinical Trial Report Overview A total of 713 idiopathic pulmonary fibrosis clinical trials were conducted as of January 2024. The Idiopathic Pulmonary Fibrosis clinical trial report provides a comprehensive understanding of the idiopathic pulmonary fibrosis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions...
-
Thematic Analysis
Blockchain – Thematic Intelligence
Blockchain Thematic Intelligence Report Overview Blockchain is a type of distributed ledger comprising unchangeable, digitally recorded data in packages called blocks. Each block is ‘chained’ to the next block using a cryptographic signature. The four key characteristics that make blockchain uniquely different from traditional databases are decentralization, cryptography, validation, and immutability. Key Features of Blockchain Technology Buy the Full Report to Know More About the Key Features of Blockchain Technology, Download a Free Report Sample With the hype around blockchain...
-
Product Insights
NewPolycystic Kidney Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Polycystic Kidney Disease Clinical Trial Report Overview A total of 238 polycystic kidney disease clinical trials were conducted as of March 2024. The polycystic kidney disease clinical trial report provides a comprehensive understanding of the polycystic kidney disease clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions...
-
Product Insights
Choroidal Neovascularization – Drugs In Development, 2023
Global Markets Direct’s, ‘Choroidal Neovascularization - Drugs In Development, 2023’, provides an overview of the Choroidal Neovascularization pipeline landscape. The report provides comprehensive information on the therapeutics under development for Choroidal Neovascularization, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Norovirus Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Norovirus Infections - Drugs In Development, 2023’, provides an overview of the Norovirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Norovirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Sharp Makueni Solar PV Park
Sharp Makueni Solar PV Park is a solar PV project located in Makueni, Kenya. The project is owned by Legacy Energy Group LLC; Rareh Icon Solar Ltd; responsAbility Africa Ltd.; Sharp Energy Solutions Corp and is developed by Legacy Energy Group LLC; Rareh Icon Solar Ltd; Sharp Energy Solutions Corp. The project is at the permitting stage. Empower your strategies with our Sharp Makueni Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report...